Oral and parenteral hypoglycaemics

Guidelines (2)

Management of Type 2 Diabetes (NICE Guideline)

Summary of NICE guidance on treatment of type 2 diabetes.

Current Medical Standards of Fitness to Drive (DVLA Guidance)

Key advice from DVLA on fitness to drive.

Tables (3)

Table: SGLT2 Inhibitors for the Treatment of Type II Diabetes

Costs, combinations and benefits of SGLT2 inhibitors.

Table: Antidiabetic Agents, Use in Renal Impairment

Dosing of diabetes drugs in patients with renal impairment.

Table: GLP-1 Agonists for the Treatment of Type II Diabetes

Dosing, costs, combinations and benefits of GLP-1 agonists.

Oral and parenteral hypoglycaemics in the News

SGLT2 inhibitors backed for cardiovascular prevention in draft NICE guidance

SGLT2 inhibitors backed for cardiovascular prevention in draft NICE guidance

SGLT2 inhibitors should be considered as first-line...

New patient-influenced diabetes guidance 'strongly recommends' SGLT2 inhibitors

New patient-influenced diabetes guidance 'strongly recommends' SGLT2 inhibitors

SGLT2 inhibitors are 'strongly recommended' for patients...

SGLT2 inhibitors summarised in new MIMS table

SGLT2 inhibitors summarised in new MIMS table

Prescribers can quickly compare key features and benefits...